top of page
Rinnit logo – modern health products and health news

Understanding Micropenis: Causes, Diagnosis, and Treatment

Oct 10
6 min read

Updated: 3 days ago

Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026

Micropenis, also called microphallus, is a medical term for a penis that is small but normally structured. It is rare, it is usually found in infancy or early childhood, and the most common cause is a testosterone deficiency during fetal development. Early hormone treatment can help stimulate growth in some people[1].

Quick Answer: What is a micropenis?

A micropenis is a normally structured penis that is significantly shorter than average for a person's age, affecting about 0.6% of people worldwide. It is most commonly caused by testosterone deficiency during fetal development. It usually does not affect urination or erections. Treatment, usually a short course of testosterone, works best when started in infancy. [1] [2]

What the research says

  • The diagnosis depends on correct measurement and a normal internal and external anatomy. A clinical review states that micropenis is diagnosed when the stretched penile length is below 2.5 standard deviations under the mean in a patient with normal internal and external male genitalia. It notes that causes include structural or hormonal defects of the hypothalamic-pituitary-gonadal axis, and that micropenis can be part of several congenital syndromes (Hatipoğlu and Kurtoğlu, J Clin Res Pediatr Endocrinol, 2013 [2]).

  • Early hormone treatment can help in a hormone-deficiency cause. A review of 12 studies including 95 infants with congenital hypogonadotropic hypogonadism, in which micropenis is a common feature, found that gonadotropin therapy in infancy produced significant penile growth and increased testicular volume. No serious adverse events were reported, and the authors call for longer studies of effects on puberty and fertility (Cammisa et al., Children, 2026 [3]).

  • Micropenis can be a sign of an underlying hormonal syndrome. In a systematic review of 125 male patients with Laron syndrome (17 articles), micropenis occurred in 67.2% of patients, and delayed puberty was common among untreated patients (Cannarella et al., Endocr Connect, 2021 [4]).

What Is a Micropenis?

A micropenis is a small but normally structured penis. Something that affects hormones or genes causes it, and healthcare providers often diagnose it from the newborn period to early childhood. It is very rare, affecting about 0.6% of people worldwide. In the United States, about 1.5 in 10,000 newborns have a micropenis at birth[1].

As long as there are no other health conditions, a micropenis can function as expected. You can still urinate and get erections[1].

How is a micropenis measured?

Providers use the stretched penile length (SPL). They gently stretch the flaccid (not erect) penis, hold a measuring tape or ruler close to the body, and measure from the tip (glans) to the base. A micropenis is diagnosed when the length is less than 2.5 standard deviations below the average for the person's age group[1][2].

Age group

Average SPL

Micropenis threshold

Newborn

1.4 inches (3.5 cm)

0.75 inches (1.9 cm) or less

Adult

5.25 inches (13.3 cm)

2.67 inches (6.8 cm) or less

Clinical reference chart titled "Diagnosis of Micropenis" comparing newborn and adult penile length ranges and diagnostic thresholds, with an illustration of stretched penile length (SPL) measurement. – rinnit.com

Stretched penile length (SPL) is the standard measurement used to diagnose micropenis.

What causes a micropenis, and what are the risk factors?

A micropenis is most commonly caused by testosterone deficiency during fetal development, which can result from several conditions. This can happen because of several conditions[1]:

  • Male hypogonadism: the most common cause. It occurs when the hypothalamus does not release the hormones that stimulate the testicles to make testosterone.

  • Genetic variations: the SRD5A2 gene makes an enzyme that helps convert testosterone into dihydrotestosterone (DHT), which is important for the development of the external genitals, including the penis.

  • Hormonal and genetic syndromes: Prader-Willi syndrome, Kallmann syndrome, and androgen insensitivity syndrome.

  • Unknown cause: sometimes there is no clear cause.

Diagram titled "Hormonal Pathways and Causes of Micropenis" showing the hypothalamus, pituitary gland, and testicles, and how testosterone deficiency or an SRD5A2 gene variation that impairs conversion to DHT can lead to micropenis. – rinnit.com

Hormonal pathways involved in typical male genital development and how they can be disrupted.

What are the symptoms of a micropenis, and what conditions are associated with it?

The main sign is a measurement below the threshold for the person's age. A micropenis can occur on its own, but it often occurs along with other health problems caused by hormonal disorders or congenital urinary abnormalities. Symptoms depend on the cause[1][2]:

  • Lower sperm count (oligospermia): some people with a micropenis have it, but not always.

  • Congenital urinary abnormalities: these may occur alongside the condition.

  • Signs of a hormonal disorder: depending on the cause, there may be other signs of low testosterone or endocrine problems.

How is a micropenis treated and managed?

People of all ages can benefit from treatment, but the chances of success are greater when the condition is diagnosed and treated in infancy. A baby with a micropenis may be referred to a pediatric urologist or endocrinologist[1].

Testosterone therapy

The first-line treatment is usually a short course of testosterone, given as injections or a skin gel. It also tests how well the penis responds to the hormone. Many infants show good penile growth, but providers are not sure whether the growth continues through puberty and adulthood. Never use testosterone injections or gels unless a provider prescribes them[1][3].

Surgery

Penis enlargement surgery may be considered if testosterone therapy does not work. If the penis functions and has adequate size, most providers do not recommend surgery because of the risk of complications and unrealistic expectations. Risks include scarring, infection, pain, loss of feeling, and erectile dysfunction. Recovery usually takes about four to six weeks[1].

Flow diagram of the micropenis treatment pathway: early diagnosis and monitoring, hormone therapy with testosterone injections or topical gel, progress evaluation, and psychological support leading to improved quality of life. – rinnit.com

Treatment combines early diagnosis, hormone therapy, regular follow-up, and psychological support.

What is the outlook for a micropenis, and how can people cope?

The outlook depends on the cause. People with a hormone deficiency usually do well, especially with early diagnosis and treatment: they usually respond well to testosterone therapy at a younger age, gain adequate penile length, and have typical function as adults. Other causes, such as androgen insensitivity syndrome, can be harder to treat, and hormone therapy cannot treat the condition in those cases[1].

Most people with a micropenis have typical sexual function. It does not affect the ability to urinate or reach orgasm. Coping can be difficult if the penis does not respond to early treatment, and talk therapy, social services, and a sex therapist can help with emotional well-being and intimacy. Penis size varies widely and does not reflect a person's worth[1].

A micropenis cannot be prevented. Caring for yourself before and during pregnancy, including regular prenatal visits, taking a daily prenatal vitamin with at least 400 mcg of folic acid, and avoiding alcohol, tobacco, and drugs a provider has not prescribed, gives your child the best start[1].

What is the bottom line on micropenis?

Micropenis is a rare condition that can be distressing, but it is often manageable with early diagnosis and the right care. If you have concerns about your child's development or your own health, talk to a healthcare provider such as a pediatric urologist or endocrinologist. Early diagnosis gives the best chance of a successful treatment outcome[1].

Frequently Asked Questions

What is the clinical definition of a micropenis?

A normally structured penis whose stretched length is more than 2.5 standard deviations below the average for the person's age group.

How is a micropenis measured?

Providers gently stretch the flaccid penis and measure from the tip to the base with a ruler or measuring tape held close to the body.

What is the most common cause of micropenis?

A testosterone deficiency during fetal development, often due to male hypogonadism.

Can a micropenis function normally?

Yes. If there are no other health conditions, a person can urinate, get erections, and reach orgasm.

Is hormone therapy effective for micropenis?

A short course of testosterone is the usual first-line treatment, and many infants show good penile growth. The chances of success are greater when treatment starts in infancy.

Does a micropenis affect fertility?

Some people with a micropenis have a lower sperm count, but this is not always the case.

At what age is micropenis usually diagnosed?

Most often from the newborn period to early childhood.

Is surgery always required for a micropenis?

No. If the penis functions and has adequate size, most providers do not recommend surgery because of the risks.

Can a micropenis be prevented?

No. It usually develops before birth because of hormonal or genetic factors.

What specialists treat micropenis?

Pediatric urologists and endocrinologists. Adults can start with a primary care provider, who can refer them to a urologist.

References

  1. Cleveland Clinic. Micropenis. Cleveland Clinic. January 7, 2026. https://my.clevelandclinic.org/health/diseases/17955-micropenis

  2. Hatipoğlu N, Kurtoğlu S. Micropenis: etiology, diagnosis and treatment approaches. J Clin Res Pediatr Endocrinol. 2013;5(4):217-223. PMID 24379029. https://doi.org/10.4274/Jcrpe.1135

  3. Cammisa I, Rigante D, Cipolla C. Gonadotropins in mini-puberty: pathophysiological and therapeutic implications for male congenital hypogonadism. Children (Basel). 2026;13(1):133. PMID 41597141. https://doi.org/10.3390/children13010133

  4. Cannarella R, Crafa A, La Vignera S, Condorelli RA, Calogero AE. Role of the GH-IGF1 axis on the hypothalamus-pituitary-testicular axis function: lessons from Laron syndrome. Endocr Connect. 2021;10(9):1006-1017. PMID 34319907. https://doi.org/10.1530/EC-21-0252

Medical disclaimer

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. The clinical information in this guide reflects source material last reviewed in January 2026.

Comments


bottom of page